Reserpine and Hydrochlorothiazide 0.125-mg/25-mg and 0.125-mg/50-mg Capsules
Author(s): Allen Loyd V Jr
Issue: Sep/Oct 2003 - After the Women's Health Initiative Trial
View All Articles in Issue
Abstract: A formulation for preparing Reserpine and Hydrochlorothiazide 0.125-mg/25-mg and 0.125-mg/50-mg Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: reserpine, hydrochlorothiazide, capsule, blood, pressure, discontinued
Related Categories: FORMULATIONS, DISCONTINUED FORMULATIONS
Download in electronic PDF format for $35